{
    "symbol": "ESPR",
    "quarter": 3,
    "year": 2022,
    "date": "2022-11-01 14:03:04",
    "content": " U.S. product revenue for the third quarter ended September 30, 2022, was $14 million, up 28% year-over-year and $40.9 million for the 9 months ended September 30, 2022 and up 47% year-over-year. Royalty revenue for the third quarter ended September 30, 2022, was $1.6 million, up 33% year-over-year and $4.2 million for the 9 months ended September 30, 2022, up 50% year-over-year. Combined royalty and partner revenue was $5 million for the third quarter ended September 30, 2022, an increase of 43% year-over-year and $15.8 million for the 9 months ended September 30, 2022, a decrease of 55% year-over-year. Finally, total revenue for the third quarter ended September 30, 2022, was $19 million, an increase of 32% year-over-year and $56.7 million for the 9 months ended September 30, 2022, a decrease of 10% year-over-year. Turning to expenses; R&D expenses for the third quarter ended September 30, 2022, were $29.1 million, an increase of 15% year-over-year and $85.9 million for the 9 months ended September 30, 2022, an increase of 10% year-over-year. SG&A expenses were $25 million for the third quarter ended September 30, 2022, a decrease of 36% year-over-year and $84.9 million for the 9 months ended September 30, 2022, a decrease of 42% year-over-year."
}